Patents by Inventor Bodo SPECKMANN

Bodo SPECKMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240180978
    Abstract: The current invention concerns preparations comprising probiotic strains belonging to the genus Lactobacillus in combination with the amino acid L-tryptophan.
    Type: Application
    Filed: February 28, 2022
    Publication date: June 6, 2024
    Applicant: EVONIK OPERATIONS GMBH
    Inventors: Bodo SPECKMANN, Michael SCHWARM, Michael SCHILLING
  • Publication number: 20240156882
    Abstract: The current invention concerns preparations comprising at least one probiotic strain belonging to the species Lactobacillus helveticus, Lactobacillus rhamnosus (Lacticaseibacillus rhamnosus), Lactobacillus mucosae (Limosilactobacillus mucosae), and Lactobacillus johnsonii and anthocyanins.
    Type: Application
    Filed: February 28, 2022
    Publication date: May 16, 2024
    Applicant: EVONIK OPERATIONS GMBH
    Inventors: Heike TOM DIECK, Michael SCHILLING, Michael SCHWARM, Bodo SPECKMANN
  • Publication number: 20230128187
    Abstract: A preparation comprising probiotic strains belonging to the genera Bacillus sp., Lactobacillus sp., optionally Pediococcus sp. as viable cells or cytoplasmic extract thereof, and proteases, wherein the strains can degrade peptide sequences of gliadins. The preparation can be used to produce gluten-free foods from gluten-containing cereals or to treat gluten-related disorders.
    Type: Application
    Filed: November 27, 2020
    Publication date: April 27, 2023
    Applicant: Evonik Operations GmbH
    Inventors: Bodo SPECKMANN, Michael SCHWARM, Stefan PELZER, Thomas BERNGRUBER, Marco GOBBETTI, Raffaella DI CAGNO
  • Publication number: 20230042485
    Abstract: This invention concerns a process to identify consortia of probiotic strains belonging to e.g. the genera Lactobacillus, Bacillus, Pediococcus, and Weissella that can be used in preparations for food supplement, food production, and pharmaceutical applications with the intention to execute a safe and rapid degradation of gluten to non-toxic, non-immunogenic digests.
    Type: Application
    Filed: November 27, 2020
    Publication date: February 9, 2023
    Applicant: Evonik Operations GmbH
    Inventors: Bodo SPECKMANN, Michael SCHWARM, Stefan PELZER, Thomas BERNGRUBER, Marco GOBBETTI, Raffaella DI CAGNO
  • Publication number: 20220312816
    Abstract: The invention discloses preparations for use in enhancing formation of short-chain fatty acids (SCFAs) in a subject for treating or preventing a disease or disorder comprising at least one omega-3 fatty acid salt having an organic counter ion selected from lysine, arginine, ornithine, choline and mixtures of the same, wherein the omega-3 fatty acid is selected from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and a colon-specific delivery system.
    Type: Application
    Filed: May 18, 2020
    Publication date: October 6, 2022
    Applicant: Evonik Operations GmbH
    Inventors: Bodo SPECKMANN, Michael SCHWARM, Ines OCHROMBEL, Stefan PELZER
  • Publication number: 20220265749
    Abstract: Preparations may include at least one extract of gum resins from Boswellia species and at least one omega-3 fatty acid salt selected from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Surprisingly, such combinations of extracts of gum resins from Boswellia species and polyunsaturated fatty acid salt can cause a marked and unexpected increase in the biosynthesis of specialized pro-resolving mediators (SPM) in a synergistic manner, proposing benefit for resolution of inflammatory conditions.
    Type: Application
    Filed: July 30, 2020
    Publication date: August 25, 2022
    Applicant: Evonik Operations GmbH
    Inventors: Mario GOMEZ, Bodo SPECKMANN, Michael SCHWARM, Oliver WERZ
  • Publication number: 20220211732
    Abstract: The invention discloses preparations comprising L-rhamnose, and the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the form of either free fatty acids, fatty acid salts having an organic counter ion selected from lysine, arginine, ornithine, choline and mixtures of the same, or mixtures of free fatty acids and omega-3 fatty acid salts having an organic counter ion selected from lysine, arginine, ornithine, choline and use of a preparation as a feed or food supplement or in pharmaceutical compositions.
    Type: Application
    Filed: May 18, 2020
    Publication date: July 7, 2022
    Applicant: Evonik Operations GmbH
    Inventors: Bodo SPECKMANN, Christopher STUDTE
  • Publication number: 20220088091
    Abstract: A synbiotic preparation may include at least one probiotic strain and at least one amino acid or derivative thereof selected from glutamine, glutamic acid or salts thereof, conjugated glutamine, or oligopeptides of 2-10 amino acid units in length, wherein the amino acid units may be natural amino acids, and at least one amino acid unit being a glutamine or glutamic acid unit.
    Type: Application
    Filed: April 18, 2019
    Publication date: March 24, 2022
    Applicant: Evonik Operations GmbH
    Inventors: Ines OCHROMBEL, Bodo SPECKMANN, Stefan PELZER, Michael SCHWARM, Walter PFEFFERLE
  • Publication number: 20220016065
    Abstract: A preparation containing a mixture of at least one phospholipid, and at least one fatty acid salt of a cation with an anion derived from a fatty acid. A method for preparing such preparation and the use of such preparation to provide polyunsaturated fatty acids to cells, tissues, organs or organisms, for example in the field of cell and tissue culture, organ preservation, human or animal nutrition, or cosmetics.
    Type: Application
    Filed: November 28, 2019
    Publication date: January 20, 2022
    Applicant: Evonik Operations GmbH
    Inventors: Martin SCHILLING, Mario GOMEZ, Bodo SPECKMANN, Anne BENEDIKT, Christian KESSLER, Norbert WINDHAB, Ines OCHROMBEL
  • Publication number: 20210393565
    Abstract: The invention relates to preparation comprising at least one omega-3 or omega-6 fatty acid component selected from eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha linolenic acid, stearidonic acid, eicosatetraenoic acid, docosapentaenoic acid, linoleic acid, ?-linolenic acid, or arachidonic acid (ARA) and/or derivatives thereof for use to increase the formation of one or more specialized pro-resolving lipid mediators (SPM) by gastrointestinal microorganisms in the gastrointestinal tract of humans or animals wherein the polyunsaturated fatty acid component comprises an omega-3 or omega-6 fatty acid salt.
    Type: Application
    Filed: November 28, 2019
    Publication date: December 23, 2021
    Applicant: Evonik Operations GmbH
    Inventors: Bodo SPECKMANN, Ines OCHROMBEL, Martin SCHILLING, Mario GOMEZ, Michael SCHWARM, Stefan PELZER, Jessica KLEINBĂ–LTING, Thomas BERNGRUBER
  • Publication number: 20210392935
    Abstract: The invention relates to preparation comprising at least one probiotic strain belonging to the genus Bacillus megaterium, and a polyunsaturated fatty acid component comprising at least one omega-3 or omega-6 fatty acid selected from eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (ARA), alpha linolenic acid, stearidonic acid, eicosatetraenoic acid, docosapentaenoic acid, linoleic acid, ?-linolenic acid, wherein the polyunsaturated fatty acid component comprises an omega-3 or omega-6 fatty acid salt. The invention further relates to use of the inventive preparation as a feed or food supplement, pharmaceutical product, feed-or foodstuff compositions and for topical applications.
    Type: Application
    Filed: November 28, 2019
    Publication date: December 23, 2021
    Applicant: Evonik Operations GmbH
    Inventors: Bodo SPECKMANN, Ines OCHROMBEL, Martin SCHILLING, Mario GOMEZ, Michael SCHWARM, Stefan PELZER, Jessica KLEINBĂ–LTING, Thomas BERNGRUBER